FDA Investigator Deborah Kleinfeld
Deborah Kleinfeld has conducted inspections on 73 sites in 1 countries as of 08 Feb 2007. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
73
Last Inspection Date:
08 Feb 2007
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Deborah Kleinfeld:
Angel K Sandhu,
Anthony E Keller, RPh,
Bryan Baker,
Bryce A May,
Dennis M Farley,
Dolores E Price,
Edward D Harris,
Garrad R Poole,
Gina M Hall,
Gloria J Baca, MS,
Helen J Hamaoka,
Herbert E Arden,
Jeffrey M Watson,
Jessica L Walters Moell,
Joan A Loreng,
John A Liu,
John Cook,
Ka L Wong,
Kaarin M Slotte,
Karen J Bak,
Kenneth S Boehnen,
Lauren E Swantko,
Laurissa S Flowers,
Laverne Puckett,
LCDR Jennifer H Rhyu,
Lynn L Wong,
Mary Ewilkerson Brinsko,
Mary T Carden,
Matthew C Johns,
Melissa D Kalik,
Melody M Ragasa Leong,
Michael Davila,
Minh D Phan,
Nicholas M Smith,
Paul M Chefor,
Peter Kessler, PhD,
Rebecca E Sulpacio,
Rebecca T Davis,
Richard L Bartlett,
Roberta K Smith,
Rocco C Black,
Roger D Gawne,
Seyyida Saterfield,
Sharon L Shane,
Shelley H Beausoleil,
Shelley H Roberts,
Sherri J Jackson,
Stuart W Russell,
Sunitha K Rajaram, PhD,
Tania Y Hall,
Tonia L Sawyer,
Travis S Bradley,
William F Lagud, Jr,
William J Foust
Deborah Kleinfeld's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2001 | FDA 483 | Vitalant - Form 483, 2001-01-12 |
February, 2001 | FDA 483 | Creative Testing Solutions - Form 483, 2001-02-09 |
December, 2002 | FDA 483 | Alta Bates Summit Medical Center - Form 483, 2002-12-10 |
August, 2000 | EIR | Hawaii Lions Eye Bank and Makana Foundation - EIR, 2000-08-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more